Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nu Holdings
NU
|
+$558M |
| 2 |
Symbotic
SYM
|
+$416M |
| 3 |
Coupang
CPNG
|
+$378M |
| 4 |
Meta Platforms (Facebook)
META
|
+$334M |
| 5 |
Rivian
RIVN
|
+$320M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.52B |
| 2 |
NIO
NIO
|
+$577M |
| 3 |
Broadridge
BR
|
+$577M |
| 4 |
Mercado Libre
MELI
|
+$567M |
| 5 |
Spotify
SPOT
|
+$516M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.12% |
| 2 | Consumer Discretionary | 27.42% |
| 3 | Communication Services | 14.17% |
| 4 | Healthcare | 14.03% |
| 5 | Financials | 6.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Visa
V
$677B
| $10.2M | 0.01% |
36,646
-1,902
| -5% | -$525K |
|
|
SKYT
227
DELISTED
SkyWater Technology
SKYT
| $9.81M | 0.01% |
964,800
| – | – |
|
228
MongoDB
MDB
$32.1B
| $9.5M | 0.01% |
26,477
-1,034
| -4% | -$422K |
|
229
Tandem Diabetes Care
TNDM
$1.56B
| $9.2M | 0.01% |
259,697
-2,946
| -1% | -$78.9K |
|
230
Compañía de Cervecerías Unidas
CCU
$2.21B
| $9.12M | 0.01% |
760,470
+421,374
| +124% | +$5.04M |
|
231
Stratasys
SSYS
$774M
| $8.2M | 0.01% |
705,671
-3,066
| -0.4% | -$39.3K |
|
232
Albemarle Corp Depositary Shares
ALB.PRA
$2.64B
| $7.08M | 0.01% |
+120,000
| New | +$6.74M |
|
233
FTI Consulting
FCN
$4.18B
| $6.66M | 0.01% |
31,692
-290
| -0.9% | -$58.3K |
|
234
Fortive
FTV
$18.6B
| $6.54M | 0.01% |
100,917
-5,362
| -5% | -$325K |
|
235
Zillow
ZG
$7.63B
| $5.96M | ﹤0.01% |
124,538
-78,993
| -39% | -$4.18M |
|
236
Freshpet
FRPT
$3.22B
| $5.75M | ﹤0.01% |
49,669
-4,378
| -8% | -$423K |
|
237
EOG Resources
EOG
$70.7B
| $5.65M | ﹤0.01% |
44,208
-374
| -0.8% | -$43.7K |
|
238
GitLab
GTLB
$6.58B
| $5.44M | ﹤0.01% |
93,364
-1,079
| -1% | -$70.7K |
|
239
Golub Capital BDC
GBDC
$3.42B
| $5.11M | ﹤0.01% |
307,486
+83,787
| +37% | +$1.31M |
|
240
Globus Medical
GMED
$11.2B
| $4.88M | ﹤0.01% |
91,066
-961
| -1% | -$51.7K |
|
241
Sixth Street Specialty
TSLX
$1.81B
| $4.83M | ﹤0.01% |
225,420
+66,348
| +42% | +$1.43M |
|
242
Health Catalyst
HCAT
$128M
| $4.04M | ﹤0.01% |
536,768
-1,550
| -0.3% | -$14.1K |
|
243
Exelon
EXC
$47B
| $3.59M | ﹤0.01% |
95,638
| – | – |
|
244
RxSight
RXST
$260M
| $3.43M | ﹤0.01% |
+66,482
| New | +$3.26M |
|
245
Relay Therapeutics
RLAY
$4.33B
| $2.93M | ﹤0.01% |
353,226
-20,370
| -5% | -$199K |
|
246
Coinbase
COIN
$40.5B
| $2.78M | ﹤0.01% |
10,482
-296
| -3% | -$53.3K |
|
|
CLLS
247
Cellectis
CLLS
$285M
| $2.19M | ﹤0.01% |
827,248
+10,605
| +1% | +$29.3K |
|
248
Expensify
EXFY
$245M
| $2M | ﹤0.01% |
1,087,013
-10,435
| -1% | -$19.8K |
|
249
Alector
ALEC
$199M
| $1.94M | ﹤0.01% |
322,829
-23,095
| -7% | -$151K |
|
250
CenterPoint Energy
CNP
$26.8B
| $1.89M | ﹤0.01% |
+66,416
| New | +$1.86M |
|
Similar funds
Baillie Gifford & Co's Q1 2024 Portfolio in Review
As of Q1 2024, Baillie Gifford & Co held 303 positions worth $129B, up 1.9% from $126B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Baillie Gifford & Co withdrew a net $7.94B in Q1 2024, closing 13 positions and reducing 203 holdings. Its most notable exit was Broadridge, an estimated $577M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, Baillie Gifford & Co opened a new position in Symbotic worth $427M.
- Baillie Gifford & Co's largest Q1 2024 buy was Symbotic: 9,483,371 shares worth $427M.
- Baillie Gifford & Co added most to Nu Holdings in Q1 2024, an estimated $558M increase.
- Baillie Gifford & Co's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $2.52B.
- Baillie Gifford & Co fully exited Broadridge in Q1 2024, selling an estimated $577M.
- Baillie Gifford & Co's ten largest holdings make up 41% of its $129B portfolio in Q1 2024.
- Baillie Gifford & Co opened 15 new positions and closed 13 in Q1 2024.
- Baillie Gifford & Co's portfolio value rose 1.9% quarter-over-quarter to $129B.
Based on Baillie Gifford & Co's 13F filing for Q1 2024, filed 1 May 2024.